Clinical Trial Detail

NCT ID NCT02713386
Title Ruxolitinib Phosphate, Paclitaxel, and Carboplatin in Treating Patients With Stage III-IV Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Recruitment Active, not recruiting
Gender female
Phase Phase Ib/II
Variant Requirements No
Sponsors NRG Oncology
Indications

fallopian tube cancer

peritoneum cancer

ovary epithelial cancer

Therapies

Ruxolitinib

Carboplatin + Paclitaxel

Age Groups: adult

No variant requirements are available.